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The spindle checkpoint delays anaphase onset
in cells with mitotic spindle defects. Here, we
show that Chk1, a component of the DNA dam-
ageand replication checkpoints, protects verte-
brate cells against spontaneous chromosome
missegregation and is required to sustain ana-
phase delay when spindle function is disrupted
by taxol, but not when microtubules are com-
pletely depolymerized by nocodazole. Spindle
checkpoint failure in Chk1-deficient cells corre-
lates with decreased Aurora-B kinase activity
and impaired phosphorylation and kinetochore
localization of BubR1. Furthermore, Chk1 phos-
phorylates Aurora-B and enhances its catalytic
activity in vitro. We propose that Chk1 aug-
ments spindle checkpoint signaling and is re-
quired for optimal regulation of Aurora-B and
BubR1when kinetochoresproduce aweakened
signal. In addition, Chk1-deficient cells exhibit
increased resistance to taxol. These results
suggest a mechanism through which Chk1
could protect against tumorigenesis through
its role in spindle checkpoint signaling.
INTRODUCTION
The mitotic spindle checkpoint protects against chromo-
some missegregation by delaying sister chromatid sepa-
ration until all sister kinetochores have achieved bipolar
attachment to spindle microtubules (Kops et al., 2005).
The checkpoint is triggered by kinetochores that lack
bound microtubules, but also by lack of tension across
attached sister kinetochores. Spindle checkpoint defects
are associated with chromosomal instability, aneuploidy,
and cancer predisposition (Kops et al., 2005).
Conserved components of the spindle checkpoint path-
way include the Mad proteins Mad1, Mad2, and BubR1
(Mad3) and the Bub proteins Bub1 and Bub3 (Kops
et al., 2005). Recruitment of Mad and Bub proteins to
kinetochores of unaligned chromosomes is essential to
prevent activation of the anaphase-promoting complex/
cyclosome (APC/C) and to delay mitotic exit. BothDevelopmBubR1 and Mad2 are recruited to unattached kineto-
chores, whereas only BubR1 is detectably recruited to
kinetochores that are not under tension; however, Mad2
function is still required to delay mitotic exit in the absence
of tension (Skoufias et al., 2001; Waters et al., 1998). Acti-
vated APC/C is an E3 ubiquitin ligase that targets key
proteins, including cyclin B and securin, for degradation,
leading to initiation of anaphase and segregation of sister
chromatids (Kops et al., 2005).
The mechanisms that activate the spindle checkpoint
are incompletely understood. In budding yeast, the Ipl1/
Aurora protein kinase is required for the spindle check-
point in the absence of tension, but not when kineto-
chore-microtubule attachment is disrupted (Biggins and
Murray, 2001). It has been proposed that Ipl1/Aurora acti-
vates the checkpoint in response to tension defects and
facilitates biorientation by promoting turnover of kineto-
chore-microtubule interactions until bipolar attachment
is achieved (Cheeseman et al., 2002).
In higher eukaryotic cells, identification of the precise
role of Aurora-B is complicated by the fact that lack of
tension can generate unattached, or partially attached,
kinetochores that activate the spindle checkpoint (King
and Nicklas, 2000; Waters et al., 1998). Aurora-B catalytic
activity is required for phosphorylation and recruitment
of BubR1 to kinetochores, and inhibition of Aurora activity
or depletion of proteins that regulate Aurora-B results in
failure to sustain mitotic arrest in the absence of tension
(Carvalho et al., 2003; Ditchfield et al., 2003; Lampson
and Kapoor, 2005). The activity of Aurora-B is modulated
by the chromosomal passenger proteins INCENP and
Survivin. INCENP binds to Aurora-B via its conserved
carboxy-terminal IN box and stimulates Aurora-B activity
both in vitro and in vivo (Bishop and Schumacher, 2002;
Honda et al., 2003). Survivin binds to INCENP and contrib-
utes to full Aurora-B activity in vivo, and both INCENP and
Survivin are required for localization of Aurora-B to kinet-
ochores during prometaphase (Honda et al., 2003). During
anaphase and cytokinesis, the chromosomal passenger
complex of Aurora-B, INCENP, and Survivin transfers to
the spindle midzone and the midbody, respectively, and
participates in chromosome segregation and completion
of cytokinesis (Vagnarelli and Earnshaw, 2004).
Chk1 is a conserved protein kinase that is required to
delay the entry of cells with damaged or unreplicated
DNA into mitosis (Takai et al., 2000; Zachos et al., 2005).
Chk1 was also proposed to delay the onset of anaphaseental Cell 12, 247–260, February 2007 ª2007 Elsevier Inc. 247
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manner (Collura et al., 2005; Royou et al., 2005) and to
control the timing of mitotic entry during an unperturbed
cell cycle (Kramer et al., 2004); however, a role for Chk1
in the spindle checkpoint has not been previously
reported.
Using DT40 avian B-lymphoma cells in which Chk1 was
genetically ablated by gene targeting (Zachos et al., 2003)
and human cells in which Chk1 expression was depleted
by using small interfering RNA (siRNA), we show that
Chk1 protects against spontaneous chromosome misse-
gregation and chromosomal instability. We also show
that Chk1-deficient cells fail to sustain mitotic arrest in
the presence of taxol, a drug that stabilizes microtubules,
and that checkpoint failure is associated with decreased
Aurora-B activity and defects in phosphorylation and
localization of BubR1 to kinetochores. In contrast, Chk1
is not required for stable mitotic arrest when microtubules
are completely depolymerized by nocodazole. Chk1 asso-
ciates with kinetochores in prometaphase and is phos-
phorylated in cells treated with taxol and nocodazole,
and Chk1 kinase activity is required to maintain mitotic
arrest during treatment with taxol. Furthermore, Chk1
phosphorylates Aurora-B and enhances its catalytic activ-
ity in vitro. On the basis of the these findings, we propose
that Chk1 augments spindle checkpoint signaling to
ensure optimal regulation of Aurora-B and BubR1 and
sustained mitotic arrest when kinetochores produce a
weakened checkpoint signal. Remarkably, Chk1 is also
required for optimal tumor cell killing by taxol.
RESULTS
Chk1-Deficient Cells Exhibit Increased Levels
of Chromosome Missegregation
and Chromosomal Instability
To investigate a possible role for Chk1 in mitosis, DT40
and Chk1-deficient DT40 cells (Chk1/) stably express-
ing a histone 2B-GFP (H2B:GFP) fusion protein were
monitored through cell division by time-lapse microscopy.
This revealed that 4/12 (33%) of Chk1/ cells divided
despite visible chromosome misalignment and/or misse-
gregation of one or a few chromosomes, whereas 0/15
wild-type DT40 cells did so (Figure 1A).
Chromosome missegregation is predicted to result in
chromosomal instability. To test for this directly, we
prepared metaphase spreads of DT40 and Chk1/ cells
and counted the number of macrochromosomes. Strik-
ingly, whereas 90% of DT40 cells showed the expected
number of 12 macrochromosomes (Sonoda et al., 1998),
only 50% of Chk1/ cells were karyotypically normal;
the remainder exhibited gain or loss of a small number
of macrochromosomes (Figure 1B).
To verify these observations in a different cell type, we
depleted Chk1 expression in human BE colon carcinoma
cells by transient transfection of Chk1 siRNA (siChk1;
Figure 3C). Examination of Chk1-depleted BE cells
revealed that 10/30 (33%) of metaphases showed
misaligned chromosomes and that 12/48 (25%) of cells248 Developmental Cell 12, 247–260, February 2007 ª2007 Elsein anaphase/cytokinesis showed one or few missegre-
gated chromosomes (Figure 1C and Figure S1A, see the
Supplemental Data available with this article online), com-
pared to only 2/25 (8%) and 3/51 (6%), respectively, in
cells transfected with negative siRNA (control). Similarly,
increased chromosome missegregation during anaphase
was observed in Chk1-depleted human colon carcinoma
HCT116 and human embryonic kidney HEK293 cells
(Figure S1C). Finally, time-lapse microscopy confirmed
that 3/15 (20%) of Chk1-depleted BE cells divided with
one or few missegregated chromosomes in anaphase,
compared to 0/11 control BE cells (Figure S1B). These
results show that Chk1 is required for accurate chromo-
some segregation in both avian and human cells.
Chk1-Deficient Cells Exhibit Defects
in Recruitment of BubR1 to Kinetochores
during Unperturbed Mitosis
Recruitment of BubR1 to kinetochores is essential for
activation of the spindle checkpoint in response to
misaligned chromosomes. In all (20/20) prometaphase
DT40 cells examined by confocal microscopy, BubR1
was observed to localize to one or more kinetochores,
indicating that the spindle checkpoint was activated
(Figure 1D). In striking contrast, 8/25 (32%) of prometa-
phase Chk1/ cells examined showed no detectable
recruitment of BubR1 to any kinetochores (Figure 1D).
Similar results were obtained in Chk1-depleted BE cells,
in which 11/20 (55%) prometaphases examined showed
no detectable recruitment of BubR1 to any kinetochores
(Figure 1E; mean BubR1/CENP-B fluorescence intensity
of 0.08 ± 0.07; Table S1). In comparison, BubR1 was
observed to localize to kinetochores in 20/20 of control
prometaphase cells in which it was juxtaposed to CENP-
B, an inner centromere marker (Figure 1E), and the mean
BubR1/CENP-B fluorescence intensity was 0.61 ± 0.37
(Table S1). However, BubR1 protein levels per se were
not affected by loss of Chk1 (Figure 1F). Taken together,
these results demonstrate that Chk1 is required for opti-
mal localization of BubR1 to kinetochores during unper-
turbed mitosis, thus suggesting a novel role for Chk1 in
spindle checkpoint function.
Chk1 Localizes to Kinetochores in Prometaphase
Proteins involved in the spindle checkpoint are often
recruited to kinetochores during prometaphase. We
therefore examined localization of Chk1 during unper-
turbed mitosis by using Chk1/ cells reconstituted with
a Chk1:GFP fusion protein. Chk1:GFP localized at kineto-
chores in prometaphase cells (Figure 2A), but not during
metaphase or anaphase (data not shown). During cytoki-
nesis, Chk1:GFP was observed to concentrate at the
midbody, where it colocalized with INCENP (Figure S1D).
Chk1 Is Required for Sustained Mitotic Delay
in Response to Microtubule Stabilization,
but Not Depolymerization
To explore the role of Chk1 in the spindle checkpoint, we
examined whether Chk1 was required for mitotic arrestvier Inc.
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Mitotic Checkpoint Failure in Chk1-Deficient CellsFigure 1. Chk1-Deficient Cells Exhibit Chromosome Missegregation, Chromosomal Instability, and Defects in Localization
of BubR1 to Kinetochores during Unperturbed Mitosis
(A) Example of chromosome missegregation. A Chk1/ cell expressing H2B:GFP was analyzed by time-lapse microscopy. Phase-contrast (left
panels) and fluorescence images (right panels) of (i) metaphase and (ii) anaphase are shown. (i) Misaligned and (ii) missegregated chromosomes
are indicated by arrowheads. The scale bar is 5 mm.
(B) Distribution of macrochromosome numbers from mitotic spreads. A total of 60 metaphase spreads were counted for each cell line.
(C) BE cells transfected with negative siRNA (control) or Chk1 siRNA (siChk1) were analyzed by confocal microscopy. Examples of missegregated
chromosomes during anaphase are indicated by arrowheads. Red, CENP-B; green, a-tubulin; blue, DNA. A single image plane is shown. The scale
bar is 5 mm.
(D) Projected deconvolved image stacks of DT40 and Chk1/ cells in prometaphase. Green, BubR1; blue, DNA. The scale bar is 5 mm.
(E) Projected deconvolved image stacks of BE cells transfected as in (C). Red, BubR1; green, CENP-B; blue, DNA. The scale bar is 5 mm.
(F) Western blot analysis of BubR1 and actin.when spindle function was perturbed by using the spindle
poisons taxol and nocodazole. Taxol stabilizes microtu-
bules by preventing tubulin depolymerization and primar-
ily interferes with tension at kinetochores, although loss ofDevelopmmicrotubule attachment in a subset of kinetochores can
occur (Schiff and Horwitz, 1980). Nocodazole, on the other
hand, completely prevents microtubule polymerization
and spindle formation; thus, all kinetochores remainental Cell 12, 247–260, February 2007 ª2007 Elsevier Inc. 249
Developmental Cell
Mitotic Checkpoint Failure in Chk1-Deficient CellsFigure 2. Chk1-Deficient Cells Fail to Sustain Taxol-Induced Mitotic Arrest
(A) Chk1 colocalizes with BubR1 at kinetochores during prometaphase. Example of a Chk1/ cell expressing Chk1:GFP and analyzed by confocal
microscopy. Red, BubR1; green, Chk1:GFP; blue, DNA. A single image plane is shown. The scale bar is 5 mm.
(B and C) Mitotic index analysis of G2/M-elutriated DT40, Chk1/, and revertant (Rev) cells during treatment with (B) taxol or (C) nocodazole. pH3,
phosphorylated Ser10 of histone H3. Error bars show the standard deviation from the mean from three experiments.
(D) Upper panels: CDK1-associated histone H1 kinase activity and western blot analysis of CDK1 (Tyr15-phosphorylated and total) and actin during
treatment of G2/M-elutriated cells with taxol. Lower panels: western blot analysis of cyclin B2 and actin. Phosphorylated cyclin B2 is marked by an
asterisk.
(E) Phosphorylated cyclin B2 as a percentage of the total cyclin B2 protein during treatment of G2/M-elutriated cells with taxol. Error bars show the
standard deviation from the mean from three experiments.
(F) Endoreduplication in Chk1/ cells during treatment with taxol. Cells were treated as in (B), and the percentage of cells with greater than 4N DNA
content was determined. Error bars show the standard deviation from the mean from three experiments.completely unoccupied. Therefore, treatment with either
taxol or nocodazole delays mitotic exit in checkpoint-
proficient cells.250 Developmental Cell 12, 247–260, February 2007 ª2007 ElsDT40, Chk1/, and revertant (Rev) cells were synchro-
nized in G2/M by centrifugal elutriation to maximize accu-
mulation of mitotic cells. The elutriated G2/M cells wereevier Inc.
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index over time was determined by staining for phosphor-
ylated Serine 10 of histone H3 (pH3) and flow cytometry
(Zachos et al., 2005). Rev cells are Chk1/ cells that
re-express Chk1 encoded by a transfected transgene
(Zachos et al., 2003). As shown in Figure 2B, taxol treat-
ment induced a pronounced accumulation of DT40 and
Rev cells in mitosis that was maximal (60%–70%)
between 8 and 12 hr and was sustained for up to 20 hr.
In contrast, although the proportion of mitotic cells in
Chk1/ cultures treated with taxol initially increased,
this increase was not sustained, and the mitotic index
declined after 12 hr of treatment to baseline levels. In com-
parison, all three cell lines accumulated in mitosis similarly
when treated with nocodazole (Figure 2C).
Time-lapse analysis for up to 20 hr revealed that a similar
percentage (70%) of DT40 and Chk1/ cells expressing
H2B:GFP entered mitosis during taxol or nocodazole
treatment, as judged by chromosome condensation. In
the presence of taxol, all (40/40) mitotic DT40 cells moni-
tored remained arrested with condensed chromosomes
for the duration of the experiment, whereas the majority
(24/34, 71%) of mitotic Chk1/ cells decondensed their
chromosomes, which was preceded by the formation of
aberrant cytokinetic furrows that did not progress to com-
pletion. In contrast, all mitotic DT40 (50/50) and Chk1/
(52/52) cells monitored retained their condensed chromo-
somes during treatment with nocodazole. We conclude
that Chk1-deficient cells are unable to sustain a mitotic
delay in response to taxol, but that they can be arrested
effectively in mitosis by nocodazole.
Consistent with mitotic exit during treatment with
taxol, Chk1/ cells failed to sustain high levels of CDK1-
associated kinase activity compared to DT40 and Rev
cells (Figure 2D). This was not due to reimposition of inhib-
itory phosphorylation of CDK1 on Tyrosine 15 (Tyr15),
since the overall levels of CDK1 Tyr15 phosphorylation
in Chk1/, DT40, and Rev cells treated with taxol were
similar (Figure 2D).
Cyclin B2 is the predominant avian B-type cyclin, and
a phosphorylated isoform accumulates during mitosis
(Zachos et al., 2005). Decreased CDK1 kinase activity in
Chk1/ cells correlated with lower levels of both total
and phospho-cyclin B2 compared to DT40 and Rev (Fig-
ure 2D). Only 10%–20% of total cyclin B2 was phosphory-
lated in Chk1/ cells after 12–20 hr in taxol, compared to
50% in DT40 and Rev cells (Figure 2E). Collectively, these
data demonstrate thatChk1/cellsexitmitosis in the pres-
ence of taxol with concomitant deactivation of CDK1 kinase
activity and degradation of both total and phospho-cyclin
B2. After mitotic exit, 30% of Chk1/ cells underwent
endoreduplication and accumulated DNA content greater
than 4N, as determined by flow cytometry (Figure 2F).
Chk1 Is Required for Localization of BubR1
to Kinetochores in Response
to Microtubule Stabilization
To determine whether Chk1 influenced localization
of BubR1 or Mad2 to kinetochores during checkpointDevelopmeactivation by spindle poisons, we generated DT40 and
Chk1/ cells stably expressing a Mad2:GFP fusion
protein and examined localization of BubR1 and Mad2
by confocal microscopy. DT40 cells that were arrested
in prometaphase by taxol showed kinetochore localization
of BubR1, but not Mad2:GFP (Figure 3A). In contrast, the
majority of Chk1/ cells in prometaphase failed to local-
ize BubR1 or Mad2:GFP to kinetochores during treatment
with taxol (Figure 3A). Importantly, BubR1 colocalized with
Mad2:GFP to kinetochores both in DT40 and Chk1/ cells
treated with nocodazole, consistent with the sustained
mitotic arrest elicited by this drug in both cell types
(Figure 3B).
These observations were also verified in human cells.
Unlike control cells, BE cells depleted for Chk1 by trans-
fection of Chk1 siRNAs that target different regions of
Chk1, either as a pool or individually, failed to arrest in
mitosis when exposed to taxol (Figure 3D and Figure S2A).
Similarly, HCT116 and HEK293 cells depleted for Chk1
exhibited decreased accumulation of mitotic cells during
treatment with taxol compared to controls (Figure S2B).
Importantly, mitotic arrest of Chk1-depleted human cells
was essentially restored in the presence of nocodazole
(Figure S2C).
Failure of Chk1-depleted human cells to arrest in mito-
sis during treatment with taxol was also associated with
defects in BubR1 recruitment. As shown in Figure 3E, all
(20/20) control BE cells examined showed localization of
BubR1 to kinetochores after taxol treatment, and BubR1
was juxtaposed to CENP-B (mean BubR1/CENP-B fluo-
rescence intensity of 0.52 ± 0.35; Table S1). In contrast,
14/21 (67%) of Chk1-depleted cells showed no detectable
localization of BubR1 to kinetochores (Figure 3E) and
a mean BubR1/CENP-B fluorescence intensity of 0.05 ±
0.04 (Table S1). During treatment with nocodazole,
BubR1 localized to kinetochores in all control (25/25)
and Chk1-depleted (17/17) mitotic BE cells examined
(Figure 3F), and the mean BubR1/CENP-B fluorescence
intensity was similar in both cell types (0.44 ± 0.14 and
0.47 ± 0.19, respectively; Table S1). Taken together, these
results demonstrate that Chk1 is required for sustained
mitotic arrest and recruitment of BubR1 to kinetochores
in cells treated with taxol, but not nocodazole.
Chk1 Catalytic Activity Is Required for Sustained
Mitotic Arrest in Response to Taxol
To test whether Chk1 catalytic activity was required for
taxol-induced mitotic arrest, the mitotic index of Chk1/
cells stably expressing a kinase-dead (KD) Chk1 protein
devoid of basal catalytic activity was determined. Unlike
DT40 and Rev cells, both Chk1/ and KD cells failed to
accumulate in mitosis during taxol treatment (Figure 4A).
In addition, 25% of KD and Chk1/ cells treated with
taxol for 16 hr exhibited DNA content >4N, indicative of
polyploidy, compared to only 5% for DT40 and Rev cells
(data not shown). The relative levels of Chk1 expression
inDT40,Chk1/, Rev,andKDcellsareshown inFigure4B.
These results indicate that Chk1 kinase activity is required
to sustain mitotic arrest during treatment with taxol.ntal Cell 12, 247–260, February 2007 ª2007 Elsevier Inc. 251
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Mitotic Checkpoint Failure in Chk1-Deficient CellsFigure 3. Chk1 Is Required for Localization of BubR1 to Kinetochores during Treatment with Taxol
(A and B) Projected deconvolved image stacks of DT40 and Chk1/ cells expressing Mad2:GFP and treated with (A) taxol or (B) nocodazole for
45 min. Red, BubR1; green, Mad2:GFP; blue, DNA. The scale bar is 5 mm.
(C) Western blot analysis of total Chk1 and actin in BE cells mock transfected (mock), transfected with negative siRNA (control), or transfected with
Chk1 siRNA (siChk1).
(D) Mitotic index analysis of BE cells transfected as in (C) and treated with taxol. pH3, phosphorylated Ser10 of histone H3. Error bars show the
standard deviation from the mean from three experiments.
(E and F) Projected deconvolved image stacks of BE cells transfected as in (C) and treated with (E) taxol or (F) nocodazole for 2 hr. Red, BubR1; green,
CENP-B; blue, DNA. The scale bar is 5 mm.Chk1 Is Phosphorylated at Noncanonical Sites
during Spindle Checkpoint Activation
Chk1 became phosphorylated during taxol and
nocodazole treatments, as judged by the appearance of252 Developmental Cell 12, 247–260, February 2007 ª2007 Elseslower-migrating forms of the protein, which were sensi-
tive to lambda phosphatase (Figures 4C and 4D). This
phosphorylation was inhibited by caffeine (Figures 4C
and 4D), an inhibitor of upstream kinases ATM and ATRvier Inc.
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Mitotic Checkpoint Failure in Chk1-Deficient CellsFigure 4. Phosphorylation of Chk1 during Treatment of Cells with Spindle Poisons
(A) Chk1 kinase activity is required for taxol-induced mitotic arrest. Mitotic index analysis of G2/M-elutriated DT40, Chk1/, kinase-dead (KD), and
revertant (Rev) cells during treatment with taxol. pH3, phosphorylated Ser10 of histone H3. Error bars show the standard deviation from the mean from
three experiments.
(B) Western blot analysis of total Chk1 and actin in asynchronous cells.
(C and D) Western blot analysis of total Chk1 during treatment of G2/M-elutriated DT40 cells with (C) taxol or (D) nocodazole, in the absence or
presence of caffeine. The asterisk marks phosphorylated Chk1. Treatment of sample with l protein phosphatase (PP) is shown.
(E) Western blot analysis of total Chk1, phosphorylated Chk1 at Serine 345 (pS345), and actin. G2/M-elutriated DT40 cells were untreated (un) or were
treated with taxol or etoposide for 8 hr.
(F) Taxol-induced mitotic arrest is weakened by caffeine. Mitotic index analysis of G2/M-elutriated DT40 cells during treatment with taxol, in the
presence or absence of caffeine. pH3, phosphorylated Ser10 of histone H3.(Kumagai et al., 1998). Surprisingly, however, exposure
to taxol or nocodazole did not result in detectable phos-
phorylation of Chk1 at Serines 317 and 345 (Gatei et al.,
2003), although modification of both sites was readily
observed in cells treated with the DNA-damaging agent
etoposide (Figure 4E and data not shown). These results
indicate that Chk1 is phosphorylated at noncanonical
residues via a caffeine-sensitive pathway in cells exposed
to spindle poisons.DevelopmeDT40 or BE cells treated with caffeine exit mitotic arrest
more rapidly than control cells in the presence of taxol,
which suggests that mitotic phosphorylation of Chk1 is
important for taxol-induced mitotic delay (Figure 4F and
Figure S3A). However, Chk1 kinase activity was not
detectably increased during treatment of DT40 cells with
taxol or nocodazole (Figure S3B), and localization of
Chk1:GFP protein to kinetochores in prometaphase cells
during taxol treatment was not inhibited by caffeinental Cell 12, 247–260, February 2007 ª2007 Elsevier Inc. 253
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elucidate the functional significance of the mitotic phos-
phorylation of Chk1.
Chk1 Is Required for Aurora-B Activity
during Treatment with Taxol
The kinase activity of Aurora-B is required to sustain
mitotic arrest during exposure to taxol, but not nocoda-
zole (Ditchfield et al., 2003). Since this phenotype is
reminiscent of the one observed in Chk1-deficient cells,
we investigated whether Chk1 and Aurora interact
functionally during activation of the spindle checkpoint.
First, we examined whether mitotic phosphorylation of
Chk1 was dependent on Aurora. Inhibition of Aurora activ-
ity by VX-680 abolished phosphorylation of Serine 10 of
histone H3 (S10 H3), a physiological substrate of Aurora,
in mitotic DT40 cells (data not shown; Harrington et al.,
2004). However, phosphorylation of Chk1 in response to
taxol and nocodazole was not inhibited by VX-680, as
judged by the appearance of slower-migrating forms of
the protein (Figure 5A). Furthermore, localization of
Chk1:GFP to kinetochores during treatment of cells with
taxol or nocodazole (Figure 5B) was not sensitive to
treatment with VX-680 (Figure 5C and data not shown).
These results show that mitotic phosphorylation and lo-
calization of Chk1 to kinetochores do not require Aurora
activity.
To test whether Aurora activity is dependent on Chk1,
we first examined phosphorylation of Serine 7 of CENP-
A (pS7) as a surrogate marker of Aurora kinase activity
(Zeitlin et al., 2001). During treatment of BE cells with taxol,
all (15/15) control cells examined showed strong phos-
phorylation of pS7, indicative of activated Aurora (Fig-
ure 5D). In contrast, 10/18 (56%) of Chk1-depleted cells
showed weak or undetectable phosphorylation of pS7,
suggesting that Aurora kinase activity is diminished in
the absence of Chk1 (Figure 5D). During treatment with
nocodazole, both control (20/20) and Chk1-depleted
(22/22) cells showed strong phosphorylation of pS7
(Figure 5E).
To measure Aurora-B kinase activity directly, Aurora-B
was immunoprecipitated from control or Chk1-depleted
BE cells, and kinase assays were performed with histone
H3 as a substrate. During treatment with taxol, Aurora-B
activity was induced in control cells, but not in Chk1-
depleted cells (Figure 5F). In contrast, during treatment
with nocodazole, Aurora-B activity was similarly induced
in both control and Chk1-depleted cells and was inhibited
by VX-680 (Figure 5F). Taken together, our results show
that Chk1 is required for optimal activity of Aurora-B dur-
ing treatment with taxol, but not nocodazole. Kinetochore
localization of Aurora-B during taxol treatment, however,
was not dependent on Chk1 (Figure S4).
Finally, mitotic accumulation of DT40 and Chk1/ cells
during treatment with taxol was examined in the presence
or absence of VX-680 by using morphological criteria
(condensed chromosomes) since VX-680 eliminates
phospho-S10 H3 staining (data not shown). Inhibition of
Aurora activity by VX-680 diminished mitotic accumula-254 Developmental Cell 12, 247–260, February 2007 ª2007 Elsetion of DT40 cells and exacerbated the checkpoint defect
in Chk1/ cells (Figure 6A). This suggests that both
Chk1-dependent and Chk1-independent mechanisms
contribute to Aurora activation in response to spindle
disruption by taxol.
Chk1 Phosphorylates and Enhances Aurora-B
Catalytic Activity In Vitro
To investigate whether regulation of Aurora-B by Chk1
occurs through a direct mechanism, we examined
phosphorylation of Aurora-B by Chk1 in vitro. Recombi-
nant Chk1 protein was incubated with purified GST,
GST-Cdc25C (200–256), or KD recombinant Aurora-B
(D200A) to rule out autophosphorylation (Figure 6B).
Chk1 phosphorylated GST-Cdc25C (200–256), but not
GST alone, as previously reported (Peng et al., 1997).
Remarkably, Chk1 also phosphorylated KD Aurora-B,
and this phosphorylation was abolished in the presence
of the Chk1 inhibitor UCN-01 (Figure 6B) (Graves et al.,
2000). Chk1 also phosphorylated kinase-active Aurora-B
(Figure 6C and data not shown). We conclude that Chk1
phosphorylates Aurora-B in vitro.
We also examined the ability of Chk1 to enhance
Aurora-B-mediated phosphorylation of S10 H3 in vitro.
Recombinant Aurora-B phosphorylated S10 H3, and this
phosphorylation was enhanced by incubating Aurora-B
with GST-INCENP (826–919) (Figure 6D). Remarkably,
recombinant Chk1 also enhanced phosphorylation of
S10 H3 compared to Aurora-B alone, both in the presence
and absence of GST-INCENP (826–919) (Figure 6D). This
phosphorylation was dependent on the catalytic activity
of Aurora-B, as incubating recombinant KD Aurora-B
(D200A) with Chk1 and GST-INCENP (826–919) resulted
in very low levels of phosphorylated S10 H3 (Figure 6D).
In contrast, recombinant Chk1 was not detectably
phosphorylated by Aurora-B in vitro (data not shown).
These results show that Chk1 can modulate Aurora-B
catalytic activity in vitro.
Chk1 Is Required for Phosphorylation of BubR1
during Treatment with Taxol
Recruitment to kinetochores during mitosis correlates
with Aurora-dependent phosphorylation of BubR1
(Ditchfield et al., 2003; Lampson and Kapoor, 2005).
Consistently, phosphorylation of BubR1 during treatment
with taxol was impaired in Chk1/ cells compared to
DT40 cells, as judged by the appearance of slower-
migrating electrophoretic forms of BubR1 (Figure 6E). In
contrast, phosphorylation of BubR1 in response to noco-
dazole was similar in both cell types, and inhibition of
Aurora kinase activity with VX-680 decreased phosphory-
lation of BubR1 in DT40 cells (Figure 6E).
Similarly, depletion of Chk1 expression by siRNA in BE
cells resulted in a substantial decrease in the amount of
phosphorylated BubR1 compared to control in response
to taxol, but not when cells were treated with nocodazole
(Figure 6F). We conclude that Chk1 is required for optimal
phosphorylation of BubR1, specifically during treatment
of cells with taxol.vier Inc.
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Mitotic Checkpoint Failure in Chk1-Deficient CellsFigure 5. Chk1-Deficient Cells Exhibit Decreased Aurora Activity during Treatment with Taxol
(A) Mitotic phosphorylation of Chk1 does not require Aurora activity. Western blot analysis of total Chk1 during treatment of G2/M-elutriated DT40
cells with taxol or nocodazole, in the absence or presence of VX-680. The asterisk marks phosphorylated Chk1.
(B and C) Localization of Chk1 to kinetochores is not dependent on Aurora activity. Chk1/ cells expressing Chk1:GFP were treated with taxol or
nocodazole for 2 hr in the (B) absence or (C) presence of VX-680 and were analyzed by confocal microscopy. Red: BubR1; green, Chk1:GFP;
blue, DNA. A single image plane is shown. The scale bar is 5 mm.
(D and E) Projected deconvolved image stacks of BE cells transfected with negative siRNA (control) or with Chk1 siRNA (siChk1) and treated with (D)
taxol or (E) nocodazole for 2 hr. Red, CENP-A; green, phosphorylated Serine 7 of CENP-A (pS7); blue, DNA. The scale bar is 5 mm.
(F) BE cells transfected as in (D) were treated with taxol, nocodazole (nocod), or VX-680 for 6 hr. Upper panel: Aurora-B-associated histone H3 kinase
activity. Lower panel: western blot analysis of immunoprecipitated Aurora-B.Chk1 Is Required for Optimal Tumor
Cell Killing by Taxol
Antimitotic chemotherapeutic drugs are widely used
in cancer treatment (Kops et al., 2005). To examine
whether loss of Chk1 affects killing of tumor cells by taxol,DevelopmDT40 and Chk1/ cells were treated with increasing con-
centrations of taxol for 12 hr and washed free of the drug,
and clonogenic survival determined (Figure 7A). Strikingly,
at all doses tested, Chk1/ cells were more resistant to
killing than DT40 cells under these conditions (Figure 7A).ental Cell 12, 247–260, February 2007 ª2007 Elsevier Inc. 255
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Mitotic Checkpoint Failure in Chk1-Deficient CellsFigure 6. Chk1 Phosphorylates and Enhances Aurora-B Catalytic Activity In Vitro
(A) Treatment with VX-680 exacerbates the checkpoint defect in Chk1/ cells. Mitotic index analysis of G2/M-elutriated DT40 and Chk1/ cells
during treatment with taxol, in the presence or absence of VX-680.
(B) Upper panel: in vitro Chk1 kinase assay with GST, GST-Cdc25C (200–256), and kinase-dead (KD) Aurora-B (D200A) as substrates. Lower panel:
western blot analysis of Aurora-B.
(C) In vitro Chk1 kinase assay with kinase-active Aurora-B as substrate.
(D) Phosphorylation of histone H3 in vitro, with complexes of Aurora-B, Chk1, GST-INCENP (826–919), and kinase-dead (KD) Aurora-B (D200A).
pS10, phosphorylated Ser10. Values indicate the relative levels of pS10 of histone H3 with phosphorylation in the presence of Aurora-B arbitrarily
set to 1. CBB, Colloidal Brilliant Blue.
(E and F) Chk1 is required for taxol-induced phosphorylation of BubR1. (E) Western blot analysis of BubR1 during treatment of G2/M-elutriated cells
with taxol/nocodazole, in the presence or absence of VX-680. (F) Western blot analysis of BubR1 in BE cells transfected with negative siRNA (control)
or Chk1 siRNA (siChk1). Cells were untreated (un) or were treated with taxol/nocodazole (nocod) for 12 hr. The asterisk marks phosphorylated BubR1.To investigate the mechanism of taxol-induced cell
death, DT40 and Chk1/ cells were treated with 100 nM
taxol for 12 hr and washed free of the drug, and apoptosis
was measured by using Annexin V staining. DT40 cells256 Developmental Cell 12, 247–260, February 2007 ª2007 Elseexhibited high levels of taxol-induced apoptosis, whereas
Chk1/ cells were relatively resistant (Figure 7B). Taken
together, these results suggest that Chk1-dependent
functions are required for optimal tumor cell killing by taxol.vier Inc.
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Mitotic Checkpoint Failure in Chk1-Deficient CellsFigure 7. Chk1-Deficient Cells Are
Resistant to Killing by Taxol
(A and B) (A) Clonogenic survival and (B)
Annexin V staining of DT40 and Chk1/ cells
treated with taxol. Error bars show the
standard deviation of the mean from two
experiments. un, untreated.
(C) Model for the role of Chk1 in the spindle
checkpoint.DISCUSSION
Chk1 is a key effector of the DNA damage and replication
checkpoints; however, a role for Chk1 in spindle check-
point signaling has not been previously described. Here,
we show that Chk1-deficient cells exhibit increased levels
of spontaneous chromosome missegregation and defects
in recruitment of the spindle checkpoint protein BubR1 to
kinetochores during unperturbed mitosis. We believe that
premature mitotic entry of Chk1-deficient cells is unlikely
to fully account for this missegregation phenotype for
two reasons. First, Chk1-deficient cells that enter mitosis
prematurely exhibit a different phenotype in which the ma-
jority of chromosomes localize outside the spindle poles
(Loffler et al., 2006; Zachos et al., 2005), and this prema-
ture entry is typically followed by failed cytokinesis and
chromosome decondensation or nuclear fragmentation
(unpublished data). Second, inhibition or overexpression
of checkpoint proteins that control mitotic entry reportedly
does not result in chromosome missegregation (Loffler
et al., 2006; Stumpff et al., 2004). Instead, our data
suggest a role for Chk1 in the spindle checkpoint.
To further explore this novel, to our knowledge, role of
Chk1, we investigated whether Chk1 was required for
mitotic arrest induced by taxol, which stabilizes microtu-
bules and primarily interferes with tension at kinetochores,
or nocodazole, which completely depolymerizes microtu-
bules and abolishes both microtubule attachment and
tension. These experiments demonstrated that Chk1
was required to sustain mitotic arrest during treatment
with taxol, but not nocodazole. The failure to sustain
taxol-induced mitotic arrest was associated with impaired
Aurora-B kinase activity and diminished phosphorylationDevelopmeand localization of BubR1 to kinetochores. Furthermore,
Chk1 itself underwent phosphorylation in response to
spindle poisons and colocalized with BubR1 at kineto-
chores.
The requirement for Chk1 to sustain mitotic arrest could
be interpreted in two main ways in the light of current
models. One possibility is that lack of tension per se is
sensed via a mechanism distinct from that which detects
unattached kinetochores (Li and Nicklas, 1995; Stern and
Murray, 2001) and would predict a specific role for Chk1 in
the tension-sensing mechanism.
Alternatively, because loss of tension can produce
unoccupied or partially occupied kinetochores (King and
Nicklas, 2000; Waters et al., 1998), the checkpoint signal
generated when all kinetochores are completely unoccu-
pied during microtubule depolymerization by nocodazole
may simply be stronger than that which emanates from
a subset of partially occupied kinetochores during micro-
tubule stabilization by taxol. According to this model,
sustained activation of the spindle checkpoint under the
latter conditions might require Chk1 to amplify the
relatively weaker checkpoint signal.
Although we cannot distinguish unambiguously
between these possibilities at present, it is possible to
propose a model for the role of Chk1 in the spindle check-
point that accommodates our observations (Figure 7C).
During activation of the spindle checkpoint, Chk1
becomes phosphorylated via a caffeine-sensitive path-
way and is available to associate with kinetochores.
In response to checkpoint signals emanating from a
minority of kinetochores or to microtubule stabilization
by taxol, Chk1 is required for optimal Aurora-B kinase
activity, phosphorylation and localization of BubR1 tontal Cell 12, 247–260, February 2007 ª2007 Elsevier Inc. 257
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checkpoint signals generated in response to loss of micro-
tubule attachment at many or all kinetochores during
treatment with nocodazole achieve a sufficient level of
Aurora-B kinase activity to sustain mitotic arrest indepen-
dently of Chk1.
It was recently reported that depletion of Chk1 resulted
in mitotic arrest with misaligned chromosomes, rather
than in a spindle checkpoint defect (Tang et al., 2006).
Although this appears to be at odds with findings from
our study, a similar paradox has been reported for several
kinetochore proteins (Nuf2R, Ndc80Hec1, Nnf1R); partial
depletion of the proteins (80%) engages the spindle
checkpoint, whereas almost complete depletion (99%)
inactivates it (McAinsh et al., 2006; Meraldi et al., 2004).
Therefore, the difference between the results of Tang
et al. (2006) and our observations may be due to different
degrees of Chk1 depletion.
Our model raises several important questions regarding
regulation of Chk1 in response to spindle perturbations,
modulation of Aurora-B activity by Chk1, and the potential
role of Chk1 in tumor cell killing by antimitotic agents.
The first concerns the identity of the kinase responsible
for mitotic Chk1 phosphorylation and the functional signif-
icance of this modification. ATM and ATR are widely
accepted as caffeine-sensitive upstream regulators of
Chk1 (Kumagai et al., 1998); however, phosphorylation
of Chk1 during spindle checkpoint signaling does not
affect the Ser317 or Ser345 sites conventionally targeted
by these kinases (Gatei et al., 2003). This suggests either
that ATM and ATR have the potential to phosphorylate
Chk1 at alternative, noncanonical sites during mitosis, or
that mitotic phosphorylation of Chk1 is mediated by a
different caffeine-sensitive kinase. Recently, the spindle
checkpoint protein TTK/hMps1 was shown to phosphory-
late Chk2 (Wei et al., 2005), and Chk1 was proposed to be
a substrate for CDK1 (Shiromizu et al., 2006). Mitotic
phosphorylation of Chk1 was not required for its subcellu-
lar localization, and Chk1 catalytic activity was not detect-
ably induced during treatment with spindle poisons,
although it was necessary for sustained mitotic arrest. It
is possible that mitotic phosphorylation stimulates the
kinase activity of a subset of Chk1 molecules; however,
this is difficult to detect in our kinase assay. Alternatively,
the basal catalytic activity of Chk1 might be sufficient for
its role in the spindle checkpoint, and phosphorylation of
Chk1 might facilitate recognition of spindle checkpoint-
relevant substrates. Further work, including mapping of
the unidentified modification sites, is required to distin-
guish between these alternatives.
INCENP directly modulates Aurora-B catalytic activity
through allosteric interaction, whereas Survivin regulates
binding of INCENP to Aurora-B (Carvalho et al., 2003;
Honda et al., 2003). We showed that Chk1 phosphorylates
Aurora-B and enhances its catalytic activity in vitro. It is
possible that Chk1 phosphorylates Aurora-B to directly
upregulate its kinase activity. Alternatively, Chk1 might
enhance Aurora-B activity in vitro through some form of
allosteric interaction. In the latter case, phosphorylation258 Developmental Cell 12, 247–260, February 2007 ª2007 Elseof Aurora-B by Chk1 might serve in vivo to stabilize the
interaction between INCENP and Aurora-B under condi-
tions of checkpoint activation. To our knowledge, Chk1
is the first kinase shown to phosphorylate Aurora-B,
although regulatory autophosphorylation has been re-
ported (Yasui et al., 2004). Further studies are under way
to map the Chk1-phosphorylation sites of Aurora-B and
to investigate the importance of this phosphorylation for
Aurora-B activity and spindle checkpoint signaling.
Inhibition of spindle checkpoint function is a potential
anticancer strategy because it can induce massive chro-
mosome missegregation, which leads to tumor cell death
(Harrington et al., 2004). Strikingly, we observed that
Chk1/ tumor cells are more resistant to taxol-induced
apoptotic cell death. It is possible that Chk1 is required
to prevent cells with chromosomal instability from adapt-
ing, or that Chk1-mediated apoptosis prevents the sur-
vival of aneuploid cells that breach the spindle checkpoint.
Similarly, BubR1 is required for apoptosis of abnormal
mitotic cells (Shin et al., 2003). Understanding the mecha-
nisms of Chk1-dependent cell killing during chronic
checkpoint-mediated mitotic arrest may provide new
prospects for improving cancer treatment.
EXPERIMENTAL PROCEDURES
For antibodies, cell lines, plasmids, and proteins, see Supplemental
Data.
Cell Culture and Treatments
Avian B-lymphoma DT40 cells were grown and elutriated as described
(Zachos et al., 2005). Human colon carcinoma BE (a gift from S. Wilkin-
son and C. Marshall), HCT116 cells, and human embryonic kidney
HEK293 cells were grown in DMEM (GIBCO) containing 10% fetal
bovine serum at 37C in 5% CO2. Cells were treated with 1 mg/ml
nocodazole, 10 mM taxol, 5 mM caffeine, 60 mM aphidicolin, 1 mM
etoposide (all from Sigma), and 3 mM VX-680 (Kava Technology), as
appropriate.
RNA Interference
Negative siRNA or siRNA duplexes designed to repress Chk1 (Dhar-
macon) were transfected into BE, HCT116, or HEK293 cells 48 hr prior
to analysis or treatment with drugs by using OligofectAMINE (Invitro-
gen). A pool of Chk1 siRNAs was used unless otherwise stated. The
siRNA sequences are available upon request.
Indirect Immunofluorescence Microscopy
Cells were fixed in 4% paraformaldehyde in cytoskeleton buffer (1.1 M
Na2HPO4, 0.4 M KH2PO4, 137 mM NaCl, 5 mM KCl, 2 mM MgCl2,
2 mM EGTA, 5 mM PIPES, 5 mM glucose [pH 6.1]) for 5 min at 37C;
permeabilized in 0.15% Triton X-100 in cytoskeleton buffer, and immu-
nostained as appropriate. Fluorescence intensities were quantified by
using ImageJ (NIH, USA). Background readings were subtracted, and
the BubR1 values were normalized against the CENP-B signal.
Western Blotting
Cells were lysed in ice-cold whole-cell extract buffer (20 mM HEPES,
5 mM EDTA, 10 mM EGTA, 0.4 M KCl, 0.4% Triton X-100, 10% glyc-
erol, 5 mM NaF, 50 ng/ml Okadaic acid, 1 mM DTT, 5 mg/ml Leupeptin,
50 mg/ml PMSF, 1 mM Benzamidine, 5 mg/ml Aprotinin, 1 mM Na3VO4)
for 30 min on ice. Lysates were cleared by centrifugation at 15,0003 g
for 10 min. Densitometric analysis was performed with Quantity One
(Biorad).vier Inc.
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Immunoprecipitation-kinase assays for CDK1 with histone H1 as a
substrate were performed as described (Zachos et al., 2005).
For Chk1 immunoprecipitation-kinase assays, see Supplemental
Data.
For in vitro Chk1 kinase assays, 0.5 mg human recombinant Chk1
was incubated with 1 mg protein substrate in 20 ml kinase buffer
(20 mM MOPS [pH 7.2], 5 mM EGTA, 10 mM MgCl2, 25 mM sodium
b-glycerophosphate, 1 mM Na3VO4, 1 mM DTT, 100 mM ATP, 1 mCi
g-ATP) for 20 min at 30C, prior to analysis by SDS-PAGE. Where
appropriate, 145 ng UCN-01 was included in the reaction.
Aurora-B immunoprecipitation-kinase and in vitro kinase assays
were performed essentially as described (Honda et al., 2003). For
in vitro Aurora-B kinase assays, reactions were analyzed by western
blotting with polyclonal antibody against phospho-Ser10 of histone
H3 (Upstate Biotechnology). After transferring to nitrocellulose, histone
H3 that remained on the gel was visualized by staining with Colloidal
Brilliant Blue (Sigma).
Metaphase Spreads
Cells were treated with 100 ng/ml colchicine (Sigma) for 3 hr, swollen
in 0.075 M KCl at 37C for 20 min, fixed twice in fresh fixative (metha-
nol:glacial acetic acid, 3:1) for 10 min at room temperature, and drop-
ped onto slides. Spreads were stained with DAPI and were visualized
by fluorescence microscopy.
Clonogenic Cell Survival and Annexin Assays
Clonogenic survival assays were performed by using methylcellulose
(Sigma) semisolid medium as described (Zachos et al., 2003). An
Annexin V kit (Pharmigen) was used to detect apoptotic cells by flow
cytometry.
Supplemental Data
Supplemental Data include a description of the antibodies, cell lines,
plasmids, and recombinant proteins used and are available at http://
www.developmentalcell.com/cgi/content/full/12/2/247/DC1/.
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